118 related articles for article (PubMed ID: 27018418)
1. Cervical cancer screening in Greenland, 1997-2011: Screening coverage and trends in the incidence of high-grade cervical lesions.
Holst S; Wohlfahrt J; Kjær SK; Kamper-Jørgensen M; Kern P; Andersson M; Koch A
Gynecol Oncol; 2016 Nov; 143(2):307-312. PubMed ID: 27018418
[TBL] [Abstract][Full Text] [Related]
2. Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study.
Tai YJ; Chen YY; Hsu HC; Chiang CJ; You SL; Chen CA; Cheng WF;
J Gynecol Oncol; 2018 Jul; 29(4):e55. PubMed ID: 29770625
[TBL] [Abstract][Full Text] [Related]
3. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
[TBL] [Abstract][Full Text] [Related]
4. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women.
Loopik DL; IntHout J; Ebisch RMF; Melchers WJG; Massuger LFAG; Siebers AG; Bekkers RLM
Gynecol Oncol; 2020 Apr; 157(1):195-201. PubMed ID: 31973912
[TBL] [Abstract][Full Text] [Related]
5. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cervical precancers among HIV-seropositive women.
Massad LS; Xie X; D'Souza G; Darragh TM; Minkoff H; Wright R; Colie C; Sanchez-Keeland L; Strickler HD
Am J Obstet Gynecol; 2015 May; 212(5):606.e1-8. PubMed ID: 25499260
[TBL] [Abstract][Full Text] [Related]
7. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LC; Cuzick J; Myers O; Castle PE; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
[TBL] [Abstract][Full Text] [Related]
8. Immigration, screening, and cervical cancer incidence: an application of Age-Period-Cohort analysis.
Bucchi D; Chiavarini M; Bianconi F; Galeotti ME; Gili A; Stracci F
Eur J Cancer Prev; 2019 Nov; 28(6):529-536. PubMed ID: 30431461
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
[TBL] [Abstract][Full Text] [Related]
10. Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing.
Uijterwaal MH; Polman NJ; Van Kemenade FJ; Van Den Haselkamp S; Witte BI; Rijkaart D; Berkhof J; Snijders PJ; Meijer CJ
Cancer Prev Res (Phila); 2015 Jun; 8(6):502-8. PubMed ID: 25776933
[TBL] [Abstract][Full Text] [Related]
11. Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel.
Bassal R; Schejter E; Bachar R; Shapira H; Kaufman Z; Cohen D; Keinan-Boker L
Arch Gynecol Obstet; 2015 Aug; 292(2):405-13. PubMed ID: 25690481
[TBL] [Abstract][Full Text] [Related]
12. Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
BMJ Open; 2016 Aug; 6(8):e011981. PubMed ID: 27515759
[TBL] [Abstract][Full Text] [Related]
13. Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012.
Baldur-Felskov B; Munk C; Nielsen TS; Dehlendorff C; Kirschner B; Junge J; Kjaer SK
Cancer Causes Control; 2015 Aug; 26(8):1105-16. PubMed ID: 26033777
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Risk for Noncervical Anogenital Cancer in Women with Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A Danish Nationwide Cohort Study.
Sand FL; Munk C; Jensen SM; Svahn MF; Frederiksen K; Kjær SK
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1090-7. PubMed ID: 27358257
[TBL] [Abstract][Full Text] [Related]
15. Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.
Smelov V; Elfström KM; Johansson AL; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
Int J Cancer; 2015 Mar; 136(5):1171-80. PubMed ID: 25043476
[TBL] [Abstract][Full Text] [Related]
16. Screening for cancer of the uterine cervix in Greenland.
Nielsen NH; Jensen H
APMIS; 1993 Apr; 101(4):290-4. PubMed ID: 8323738
[TBL] [Abstract][Full Text] [Related]
17. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
18. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
19. Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.
Gage JC; Katki HA; Schiffman M; Fetterman B; Poitras NE; Lorey T; Cheung LC; Castle PE; Kinney WK
Int J Cancer; 2015 Apr; 136(7):1665-71. PubMed ID: 25136967
[TBL] [Abstract][Full Text] [Related]
20. A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
Hammer A; Demarco M; Campos N; Befano B; Gravitt PE; Cheung L; Lorey TS; Poitras N; Kinney W; Wentzensen N; Castle PE; Schiffman M
Int J Cancer; 2020 Sep; 147(6):1612-1620. PubMed ID: 32141607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
